Clinical Trial Update: Angiotensin II Antagonist in Severe Sepsis [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 Angiotensin II antagonist in severe sepsis. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Angiotensin II antagonist

Snippet

Sponsor: University of Salerno | Conditions: Severe Sepsis | Phase 3 | Status: UNKNOWN